<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-049970</identifier>
<setSpec>0001-6640</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Tyrosinemia type I: two atypical forms of clinical presentation</dc:title>
<dc:description xml:lang="en">The authors describe two cases of tyrosinemia type 1 with atypical clinical presentation. The first patient presented with refractory seizure secondary to hypoglycemic episodes. The metabolic study for the differential diagnosis of hypoglycemi, revealed a pattern suggestive of tyrosinemia type I. In the second patient the presence of tyrosinemia was detected during a hospital stayowing to bronchitis. In both cases, treatment with 2-(2-nitro-4, trifluoromethylbenzoyl)-1,3-cyclohexane(NTBC) combine (with a low protein diet supplemented with a tyrosine-and phenylalanine-free formula was prescribed. There have beenn no complications during the follow-up period in either case and, at the present time, the clinical and analytical findings are normal</dc:description>
<dc:creator>García Romero, R</dc:creator>
<dc:creator>Gómez López, L</dc:creator>
<dc:creator>Lambruschini, N</dc:creator>
<dc:creator>Arellano, M</dc:creator>
<dc:creator>Gutiérrez, A</dc:creator>
<dc:creator>Ribes, A</dc:creator>
<dc:creator>Arranz, J. A</dc:creator>
<dc:creator>García Puig, R</dc:creator>
<dc:creator>Vilaseca, M. A</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Se exponen dos casos de tirosinemia tipo I con presentación atípica. El primero se inicia con crisis convulsivas secundarias a hipoglucemias graves. En el estudio metabólico para el diagnóstico de las hipoglucemias se detecta un perfil típico de tirosinemia tipo I en sangre y orina. El segundo caso fue un hallazgo casual en el contexto de un ingreso por bronquitis. Ambos casos siguen tratamiento con 2-(2-nitro-4-trifluorometilbenzoil}-1-3-ciclohexanediona( NTBC) en combinación con dieta con bajo contenido en proteínas naturales suplementas con fórmula especial sin tirosina ni fenilalanina. En la actua.lidad no presentan alteraciones clínico-analíticas ni complicaciones</dc:description>
<dc:source>Acta Pediatr Esp;64(6): 286-289, jun. 2006. ilus, tab</dc:source>
<dc:identifier>ibc-049970</dc:identifier>
<dc:title xml:lang="es">Tirosinemia tipo I: dos formas atípicas de presentación clínica</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d7399</dc:subject>
<dc:subject>^d7181^s22012</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d2020^s22012</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d34235^s22016</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:type>article</dc:type>
<dc:date>200606</dc:date>
</metadata>
</record>
</ibecs-document>
